Development of a new Cox model for predicting long-term survival in hepatitis cirrhosis patients underwent transjugular intrahepatic portosystemic shunts

Figure 1 Flow chart of patient inclusion and allocation. TIPS: Transjugular intrahepatic portosystemic shunt; HCC: Hepatocellular carcinoma.

Figure 2 Reasonable shunts, indicated by orange arrows.

Figure 3 Nomogram of the newly developed Cox model for predicting 6-year survival after transjugular intrahepatic portosystemic shunt implantation in patients with hepatitis cirrhosis. ICGR15: Indocyanine green retention rate at 15 min; PVP: Portal venous pressure; Tbil: Total bilirubin.

Figure 4 Six-year receiver operating characteristic curves of different models. A: The training set; B: The validation set. NDC: Newly developed Cox; MELD: Model for end-stage liver disease; FIPS: Freiburg index of post-transjugular intrahepatic portosystemic shunt survival.

Figure 5 Calibration plots for the actual and predicted probabilities of the nomograms predicting 6-year survival after transjugular intrahepatic portosystemic shunt. A: The training cohort; B: The validation cohort.

Figure 6 Kaplan-Meier survival plot of overall survival after transjugular intrahepatic portosystemic shunt in patients with hepatitis cirrhosis, stratified according to the newly developed Cox risk groups. A: The training set; B: The validation set.